ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

ORIC Oric Pharmaceuticals Inc

9,71
0,19 (2,00%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Oric Pharmaceuticals Inc ORIC NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,19 2,00% 9,71 00:00:02
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
9,77 9,48 10,05 9,71 9,52
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
03.5.202422:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
15.4.202422:15GLOBEORIC Pharmaceuticals Announces First Patients Dosed Across..
08.4.202414:00GLOBEORIC Pharmaceuticals Presents Preclinical Data on Two..
05.4.202422:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
04.4.202422:30GLOBEORIC Pharmaceuticals to Participate in Upcoming Investor..
11.3.202422:28EDGAR2Form S-3ASR - Automatic shelf registration statement of..
11.3.202421:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11.3.202421:10EDGAR2Form 8-K - Current report
11.3.202421:05GLOBEORIC Pharmaceuticals Reports Fourth Quarter and Full Year..
06.3.202422:30GLOBEORIC Pharmaceuticals to Present at the Leerink..
05.3.202422:30GLOBEORIC Pharmaceuticals Announces Multiple Presentations at the..
01.3.202422:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
14.2.202422:30GLOBEORIC Pharmaceuticals to Participate in the Citi 2024 Virtual..
05.2.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
02.2.202422:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
31.1.202422:30GLOBEORIC Pharmaceuticals to Participate in Upcoming Investor..
26.1.202422:58EDGAR2Form S-3 - Registration statement under Securities Act of..
25.1.202419:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
22.1.202415:01EDGAR2Form 8-K - Current report
22.1.202414:30GLOBEORIC Pharmaceuticals Announces $125 Million Private..
09.1.202415:00EDGAR2Form 8-K - Current report
08.1.202414:30GLOBEORIC Pharmaceuticals Provides Initial Phase 1b Data for..
02.1.202422:30GLOBEORIC Pharmaceuticals to Present at the 42nd Annual J.P...
15.12.202322:32EDGAR2Form S-3 - Registration statement under Securities Act of..
11.12.202322:05EDGAR2Form 8-K - Current report
11.12.202318:00GLOBEInitial Phase 1 Dose Escalation Data for ORIC-533 in..
01.12.202322:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
09.11.202322:30GLOBEORIC Pharmaceuticals to Participate in Upcoming Investor..
06.11.202322:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.11.202322:10EDGAR2Form 8-K - Current report
06.11.202322:10GLOBEORIC Pharmaceuticals Reports Third Quarter 2023 Financial..
03.11.202321:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
02.11.202314:00GLOBEORIC Pharmaceuticals to Present Initial Phase 1b Clinical..
23.10.202322:07EDGAR2Form 8-K - Current report
21.10.202313:30GLOBEInitial Phase 1 Dose Escalation Data of ORIC-114 in Patients..
17.10.202322:30GLOBEORIC Pharmaceuticals to Present Initial Phase 1b Clinical..
06.10.202322:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
20.9.202322:30GLOBEORIC Pharmaceuticals to Participate in the 2023 Cantor..
01.9.202322:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
30.8.202322:30GLOBEORIC Pharmaceuticals to Participate in Upcoming Investor..
10.8.202322:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.8.202322:11EDGAR2Form 8-K - Current report
10.8.202322:05GLOBEORIC Pharmaceuticals Reports Second Quarter 2023 Financial..
04.8.202322:30GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
07.7.202322:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26.6.202314:30GLOBEORIC Pharmaceuticals Announces $85 Million Private Placement..
02.6.202322:15GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..
31.5.202322:10GLOBEORIC Pharmaceuticals to Participate in the Jefferies..
08.5.202322:05GLOBEORIC Pharmaceuticals Reports First Quarter 2023 Financial..
05.5.202322:15GLOBEORIC Pharmaceuticals Reports Inducement Grants under Nasdaq..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock